Trump admin $21M gambit for Pepcid as a COVID remedy fizzles

The Trump Administration pushed through a $21 million contract to study whether the active ingredient in Pepcid is an effective treatment for Covid-19.  The Food and Drug Administration gave the clinical trial speedy approval even as a top agency official worried that daily injections of high doses of famotidine for already sick patients pushed the levels of what was considered safe “to the limits,” internal government emails show. And the doctors who initially pushed the Pepcid